View abstracts of studies supported by our research funding.

 
Select Filters
Apply Filters
Reset Filters

Structural Targeting of TREM2 in Alzheimer's Disease

Thomas Brett, Ph.D.
St. Louis , MO - United States
2025

Defining Short RNA Therapeutics that Reverse TDP-43 Proteinopathy

James Shorter, Ph.D.
Philadelphia, PA - United States
2025

Moving Beyond Amyloid and Tau to Capture the Biological Heterogeneity of Alzheimer's Disease

Tracy Young-Pearse, Ph.D.
Cambridge, MA - United States
2025

Aging and Dementia Research and Training (ADRET) Program in Uganda

Francis Bajunirwe, Ph.D.
Mbarara, Uganda
2024

U.S. POINTER Alumni Extension

Laura Baker
Winston-Salem, NC - United States
2024

Apolipoprotein E receptors as drug targets in Alzheimer's disease

Abdel Ali Belaidi, Ph.D.
Parkville, Australia
2024

Mapping the X Chromosome Multi-Ome in Alzheimer's and Parkinson's Disease

Michaël Belloy, Ph.D.
St. Louis, MO - United States
2024

Probing Vulnerability in Circuits for Social Behavior in FTD

Kristen Berendzen, Ph.D.
San Francisco, CA - United States
2024

Identifying mechanisms of an African-specific locus protective for AD

Luciana Bertholim Nasciben, Ph.D.
Miami, FL - United States
2024

Impaired Neuronal Cytoarchitecture in AD/ADRD

Merci Best, Ph.D.
Ann Arbor, MI - United States
2024

Myelin Loss and Cognitive Impairment Following SARS-CoV-2 Infection

Narlon Cassio Boa Sorte Silva, Ph.D.
Vancouver, Canada
2024

Targeting EV-Mediated Tau Propagation via P2X Purinoreceptor 7

Victor Bodart-Santos, Ph.D.
Jacksonville, FL - United States
2024

Relationship Between Sleep, Tau, and Race in Preclinical Alzheimer disease

Anthony Briggs, Ph.D.
New York, NY - United States
2024

Role of the transcription factor PU.1 in Alzheimer's Disease

Simone Brioschi, Ph.D.
St. Louis, MO - United States
2024

Neuroprotective Effects of "Hypothermia in a Syringe"

Sonja Broeer, D.V.M., Ph.D.
Berlin, Germany
2024

Investigating the Neurophysiologic Impact of Amyloid Removal Therapy in AD

Stephanie Buss, M.D.
Boston, MA - United States
2024

Fostering Equitable Dementia Care for Hispanic/Latino Communities

Sara Bybee, Ph.D.
Salt Lake City, UT - United States
2024

Restoring Depalmitoylation in Alzheimer’s Disease Cellular and Mouse Models

Skarleth Cardenas Romero, Ph.D.
Brookline, MA - United States
2024

Stratifying ARIA risk with cerebral amyloid angiopathy biomarkers

Andreas Charidimou, M.D., Ph.D.
Boston, MA - United States
2024

Proteomics Profiling of Microglia for Cognitive Resilience in AD

Yu Chen, Ph.D.
Ann Arbor, MI - United States
2024

Social isolation and dementia risk: cross-national and temporal comparison

Ruijia Chen, ScD
Lexington, MA - United States
2024

Glymphatic Activity and Preclinical Alzheimer's Disease Pathogenesis

Gawon Cho, Ph.D.
New Haven, CT - United States
2024

CODEX Trial

Stephen Choi, Ph.D.
Toronto, Canada
2024

Endosomal Control of Protein Synthesis in Alzheimer’s Disease

Jean-Michel Cioni, Ph.D.
Milan, Italy
2024

Developing CRISPR genome therapy for Alzheimer's disease

Claire Clelland, M.D, Ph.D.
San Francisco, CA - United States
2024

Identification of Functional Cis-regulatory Elements of APP

Jesse Cochran, Ph.D.
Huntsville, AL - United States
2024

Decoding the signaling contexts underlying human glial cell-state landscape

Natacha Comandante-Lou, Ph.D.
New York, NY - United States
2024

Therapeutic potential of nicotinic acid in PS19 tauopathy mice

Israel Coronel-Morales, Ph.D.
Indianapolis, IN - United States
2024

Epidemiology and deep phenotyping of Argentinian patients with tauopathies

Blas Couto, Ph.D.
Buenos Aires, Argentina
2024

Resilience in Andean American Indigenous with Alzheimer's disease

Nilton Custodio, M.D., Ph.D.
Lima, Peru
2024

1 2 3 4 5 6 7 8 9 10... >|